Endometriosis medical research and health impacts

Medical research and clinical observations highlight the complex nature of endometriosis, a condition where uterine-like tissue grows outside the uterus. Early reports suggest that genetic and epigenetic factors, including DNA methylation and histone modifications, may influence susceptibility to the disease.

In India, significant diagnostic delays occur, with patients often waiting seven to ten years for a formal diagnosis due to a lack of early identification tools and complex referral structures. Dr. Abhishek Mangeshikar, director of the Indian Centre for Endometriosis, noted that the condition can involve various organs, including the intestines, bladder, and nerves, often requiring complex multidisciplinary care. In India alone, an estimated 27 million women suffer from the condition, which can significantly impact their career progression and work lives.

Clinical perspectives describe the condition as a ‘silent enemy’ that can lead to female infertility. This occurs through mechanisms such as local inflammation, scar tissue, and pelvic adhesions that create anatomical obstacles, potentially blocking the fallopian tubes and preventing fertilization.

Recent research offers a potential breakthrough via a modified version of the anti-parasitic drug niclosamide. To overcome poor absorption and side effects, scientists have attached the drug to microscopic water-soluble dendrimers. This targeted delivery system aims to reach disease-causing immune cells. Preclinical trials in mice showed reduced lesion size and lower pain sensitivity. This non-hormonal, non-surgical approach could provide an alternative to current treatments, which often involve invasive surgery or hormone therapies that cause side effects like osteoporosis and depression.